巴西米纳斯吉拉斯州六年常规水痘疫苗接种对水痘相关住院的影响
该回顾性观察研究分析了巴西米纳斯吉拉斯州一家儿科传染病医院2010–2019年因水痘住院的1193例患者,比较疫苗前、单剂和两剂接种期的住院变化。结果显示单剂期住院数较疫苗前下降61.5%,两剂期下降95.2%,各年龄组(含未接种者)住院率均下降,继发性细菌性皮肤感染为最常见入院原因(>70%)。
要点
- 单剂水痘疫苗期住院数较疫苗前下降61.5%,两剂期下降95.2%。
- 各年龄组住院率均下降,<12月龄未接种者下降92.1%。
- 继发性细菌性皮肤感染为最常见入院原因,占比>70%。
核心结论
- 实施水痘疫苗六年显著减少水痘住院数,对接种和未接种个体均有正面影响。
- 启动第二剂后住院进一步减少,但其真实影响需更长时间持续接种后才能充分理解。
研究设计与样本
- 在巴西米纳斯吉拉斯州一家儿科传染病医院开展的观察性回顾性研究。
- 收集2010–2019年因水痘住院患者的临床和流行病学数据,按疫苗引入分为疫苗前、单剂和两剂期进行比较。
- 研究期间共1193例因水痘住院。
主要发现
- 与疫苗前相比,单剂期住院数下降61.5%,两剂期下降95.2%。
- 所有年龄组住院率均下降,包括<12月龄未接种者下降92.1%。
- 入院原因中继发性细菌性皮肤感染最常见(>70%)。
- 免疫抑制或HIV阳性患者入院减少84.8%。
临床怎么用
- 常规水痘疫苗接种可显著降低水痘相关住院负担,支持维持并推进两剂接种策略。
- 监测应关注继发性细菌性皮肤感染等主要入院原因及未接种年龄组的间接保护效果。
局限性
- 为单中心回顾性观察研究,结果外推需谨慎。
- 第二剂真实影响需更长时间持续接种后才能充分评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The varicella vaccine was first introduced into the Brazilian immunization schedule in September 2013 as a single dose for children aged 15 months. In 2018, a second dose was recommended for individuals between 4 and 6 years old. This study aims to assess the impact of routine varicella vaccination on the number and profile of hospitalized varicella patients during the single dose period, as well as in the first two years after the adoption of the second dose. METHODS: An observational retrospective study was conducted in an infectious disease pediatric hospital, in Minas Gerais, Brazil. Clinical as well as epidemiological data from patients hospitalized due to varicella between 2010 and 2019 were collected. Patients were split into groups based on the vaccine introduction: pre-vaccine period, single dose and two-dose period. They were compared by age, sex, reason for admission, illness-related complications and clinical outcome. RESULTS: There were 1193 admissions due to varicella during the studied period. When compared with the pre-vaccine period, the number of hospitalizations decreased in 61.5% during the single-dose regime, reaching 95.2% in the two-dose period. Hospitalization rates decreased in all age groups, including non-vaccinated individuals such as those younger than 12 months (92.1%). As for reasons of admission, secondary bacterial skin infections were perceived to be the most common cause (>70%). A reduction was also seen in admission of immunocompromised or HIV positive patients (84.8%). CONCLUSION: The collected data shows a significant impact in the number of hospital admissions due to varicella after six years of the implementation of the vaccine, positively affecting both vaccinated and non-vaccinated individuals. Further reduction was seen after the second dose was initiated, but its true impact will only be understood fully after a longer period of continuous vaccination.
引用
- Abreu E Silva HB, Corrêa HP, Ribeiro IA, et al. Impact of six years of routine varicella vaccination on the disease-related hospitalizations at Minas Gerais, Brazil. Vaccine. 2021. PMID: 34507860. doi:10.1016/j.vaccine.2021.08.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。